The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
Abstract
We have analyzed the course of papillary thyroid carcinoma in 269 patients managed at the University of Chicago, with an average follow-up period of 12 yr from the time of diagnosis. Patients were categorized by clinical class; I, with intrathyroidal disease; II, with cervical nodal metastases; III, with extrathyroidal invasion; and IV, with distant metastases. Half of the patients had a history of thyroid enlargement known, on the average, for over 3 yr. In 15% of patients given thyroid hormone, the mass decreased in size. The peak incidence of cancer was when subjects were between 20-40 yr of age. Tumors averaged 2.4 cm in size; 21.6% had tumor capsule invasion, and 46% of patients had multifocal tumors. Sixty-six percent of the patients had near-total or total thyroidectomy. The overall incidence of postoperative hypoparathyroidism was 8.4%, but the incidence was zero in 83 near-total or total thyroidectomies carried out by 1 surgeon. Twenty-five percent of the patients had continuing or recurrent disease, and 8.2% died from cancer. Deaths occurred largely in patients with class III or IV disease. Cervical lymph nodes were associated with increased recurrences, but not increased deaths. Extrathyroidal invasion carried an increased risk of 5.8-fold for death, and distant metastases increased this risk 47-fold. Age over 45 yr at diagnosis increased the risk of death 32-fold. Tumor size over 3 cm increased the risk of death 5.8-fold. Surgical treatment combining lobectomy plus at least contralateral subtotal thyroidectomy was associated, by Cox proportional hazard analysis, with decreased risk of death in patients with tumors larger than 1 cm and decreased risk of recurrence among all patients, including patients in classes I and II, compared to patients who underwent unilateral thyroid surgery or bilateral subtotal resections. By chi 2 analysis, 131I ablation of residual thyroid tissue after operation was associated with decreased risk of recurrence in tumors larger than 1 cm and decreased risk of death in patients in classes I and II with tumors more than 1 cm in size. The data strongly support the use of more extensive initial surgery in class I and II patients with tumors more than 1 cm in size as well as postoperative radioactive 131I ablation of thyroid remnant tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An expanded view of risk-group definition in differentiated thyroid carcinoma.
Cady, B., & Rossi, R. (1988) · PubMed · Cited by 937
HAY, I. D., Grant, C. S., Taylor, W. F., & McConahey, W. M. (1987) · PubMed · Cited by 828
BRENNAN, M. D., BERGSTRALH, E. J., van HEERDEN, J. A., & McCONAHEY, W. M. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61170-7 · Cited by 764
Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patients
Mazzaferri, E. L., & Young, R. L. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90573-8 · Cited by 670
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
Tubiana, M., Schlumberger, M., Rougier, P., Laplanche, A., Benhamou, E., Gardet, P., Caillou, B., Travagli, J.-P., & Parmentier, C. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z · Cited by 573
PAPILLARY THYROID CARCINOMA: THE IMPACT OF THERAPY IN 576 PATIENTS
MAZZAFERRI, E. L., YOUNG, R. L., OERTEL, J. E., KEMMERER, W. T., & PAGE, C. P. (1977) · Medicine · doi:10.1097/00005792-197705000-00001 · Cited by 534
Papillary and follicular thyroid cancer
Simpson, W. J., McKinney, S. E., Carruthers, J. S., Gospodarowicz, M. K., Sutcliffe, S. B., & Panzarella, T. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90758-3 · Cited by 382
Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
Simpson, W. J., Panzarella, T., Carruthers, J. S., Gospodarowicz, M. K., & Sutcliffe, S. B. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90381-1 · Cited by 275
Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important?
Grant, C. S., HAY, I. D., Gough, I., Bergstralh, E. J., Goellner, J. R., & McConahey, W. M. (1988) · PubMed · Cited by 245
Retrospective and prospective study of radiation-induced thyroid disease
DeGroot, L. J., Reilly, M. K., Pinnameneni, K., & Refetoff, S. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91077-x · Cited by 116
Self-citation
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
Mazzaferri, E. L., & Jhiang, S. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90321-2 · Cited by 2,635
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri, E. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1447 · Cited by 1,396
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Frates, M. C., Benson, C. B., Charboneau, J. W., Cibas, E. S., Clark, O. H., Coleman, B. G., Cronan, J. J., Doubilet, P. M., Evans, D. B., Goellner, J. R., et al. (2005) · Radiology · doi:10.1148/radiol.2373050220 · Cited by 1,227
Benign and Malignant Thyroid Nodules: US Differentiation—Multicenter Retrospective Study
Moon, W.-J., Jung, S. L., Lee, J. H., Na, D. G., Baek, J.-H., Lee, Y. H., Kim, J., Kim, H. S., Byun, J. S., & Lee, D. H. (2008) · Radiology · doi:10.1148/radiol.2473070944 · Cited by 1,104
Xing, M. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0007 · Cited by 983
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
Hay, I. D., Hutchinson, M. E., Gonzalez-Losada, T., McIver, B., Reinalda, M. E., Grant, C. S., Thompson, G. B., Sebo, T. J., & Goellner, J. R. (2008) · Surgery · doi:10.1016/j.surg.2008.08.035 · Cited by 940
Sherma, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12488-9 · Cited by 925
Wada, N., Duh, Q.-Y., Sugino, K., Iwasaki, H., Kameyama, K., Mimura, T., Ito, K., Takami, H., & Takanashi, Y. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000055273.58908.19 · Cited by 815
Chow, S., Law, S. C. K., Chan, J. K. C., Au, S., Yau, S., & Lau, W. (2003) · Cancer · doi:10.1002/cncr.11442 · Cited by 723
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Stewart, A. K., Winchester, D. P., Talamonti, M. S., & Sturgeon, C. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e31814697d9 · Cited by 697
Leboulleux, S., Rubino, C., Baudin, E., Caillou, B., Hartl, D. M., Bidart, J.-M., Travagli, J.-P., & Schlumberger, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0285 · Cited by 588
Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6094 · Cited by 566
Self-citationElisei, R., Ugolini, C., Viola, D., Lupi, C., Biagini, A., Giannini, R., Romei, C., Miccoli, P., Pinchera, A., & Basolo, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0607 · Cited by 528
DANESE, D., SCIACCHITANO, S., FARSETTI, A., ANDREOLI, M., & PONTECORVI, A. (1998) · Thyroid · doi:10.1089/thy.1998.8.15 · Cited by 522
Hundahl, S. A., Cady, B., Cunningham, M. P., Mazzaferri, E., McKee, R. F., Rosai, J., Shah, J. P., Fremgen, A. M., Stewart, A. K., H�lzer, S., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<202::aid-cncr27>3.0.co;2-a · Cited by 514
Scheumann, G. F. W., Gimm, O., Wegener, G., Hundeshagen, H., & Dralle, H. (1994) · World Journal of Surgery · doi:10.1007/bf00353765 · Cited by 493
Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches
Are, C., & Shaha, A. R. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.042 · Cited by 440
Sawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., & Gerstein, H. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031167 · Cited by 432
Adam, M. A., Pura, J., Gu, L., Dinan, M. A., Tyler, D. S., Reed, S. D., Scheri, R., Roman, S. A., & Sosa, J. A. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000925 · Cited by 427
Podnos, Y. D., Smith, D., Wagman, L. D., & Ellenhorn, J. D. I. (2005) · The American Surgeon™ · doi:10.1177/000313480507100907 · Cited by 414
National Thyroid Cancer Treatment Cooperative Study Registr Group, Sherman, S. I., Brierley, J. D., Sperling, M., Ain, K. B., Bigos, S. T., Cooper, D. S., Haugen, B. R., Ho, M., Klein, I., et al. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980901)83:5<1012::aid-cncr28>3.0.co;2-9 · Cited by 402
Loh, K.-C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3553 · Cited by 396
Giordano, T. J., Kuick, R., Thomas, D. G., Misek, D. E., Vinco, M., Sanders, D., Zhu, Z., Ciampi, R., Roh, M., Shedden, K., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208822 · Cited by 383
Tsang, R. W., Brierley, J. D., Simpson, W. J., Panzarella, T., Gospodarowicz, M. K., & Sutcliffe, S. B. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<389::aid-cncr19>3.0.co;2-v · Cited by 381
Machens, A., Holzhausen, H., & Dralle, H. (2005) · Cancer · doi:10.1002/cncr.21055 · Cited by 371
AACE/AAES MEDICAL/SURGICAL Guidelines for Clinical Practice: Management of Thyroid Carcinoma
Cobin, R. H., Gharib, H., Bergman, D. A., Clark, O. H., Cooper, D. S., Daniels, G. H., Dickey, R. A., Duick, D. S., Garber, J. R., Hay, I. D., et al. (2001) · Endocrine Practice · doi:10.4158/ep.7.3.202 · Cited by 365
Hay, I. D., Grant, C. S., Bergstralh, E. J., Thompson, G. B., van Heerden, J. A., & Goellner, J. R. (1998) · Surgery · doi:10.1016/s0039-6060(98)70035-2 · Cited by 329
New developments in the diagnosis and treatment of thyroid cancer
Schneider, D. F., & Chen, H. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21195 · Cited by 316
Viola, D., Materazzi, G., Valerio, L., Molinaro, E., Agate, L., Faviana, P., Seccia, V., Sensi, E., Romei, C., Piaggi, P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3825 · Cited by 312
Parathyroid Autotransplantation During Thyroidectomy: Results of Long-Term Follow-Up
Olson, J. A., DeBenedetti, M. K., Baumann, D. S., & Wells, S. A. (1996) · Annals of Surgery · doi:10.1097/00000658-199605000-00003 · Cited by 308
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
Grogan, R. H., Kaplan, S. P., Cao, H., Weiss, R. E., DeGroot, L. J., Simon, C. A., Embia, O. M. A., Angelos, P., Kaplan, E. L., & Schechter, R. B. (2013) · Surgery · doi:10.1016/j.surg.2013.07.008 · Cited by 301
Self-citationPacini, F. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1499 · Cited by 299
Bernier, M.-O. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1568 · Cited by 299
Survival and Death Causes in Differentiated Thyroid Carcinoma
Eustatia-Rutten, C. F. A., Corssmit, E. P. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A., & Smit, J. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1322 · Cited by 287
Papillary and follicular thyroid carcinoma
Schlumberger, M. J., & Torlantano, M. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0105 · Cited by 278
Castagna, M. G., Maino, F., Cipri, C., Belardini, V., Theodoropoulou, A., Cevenini, G., & Pacini, F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0466 · Cited by 275
Sawka, A. M., Brierley, J. D., Tsang, R. W., Thabane, L., Rotstein, L., Gafni, A., Straus, S., & Goldstein, D. P. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.02.007 · Cited by 273
Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases
Kitamura, Y., Shimizu, K., Nagahama, M., Sugino, K., Ozaki, O., Mimura, T., Ito, K., Ito, K., & TANAKA, S. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4043 · Cited by 272
Vaisman, F., Momesso, D., Bulzico, D. A., Pessoa, C. H. C. N., Dias, F., Corbo, R., Vaisman, M., & Tuttle, R. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04342.x · Cited by 267
The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk
Kwong, N., Medici, M., Angell, T. E., Liu, X., Marqusee, E., Cibas, E. S., Krane, J. F., Barletta, J. A., Kim, M. I., Larsen, P. R., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3100 · Cited by 260
Management of Low-Risk Differentiated Thyroid Cancer
Mazzaferri, E. L. (2007) · Endocrine Practice · doi:10.4158/ep.13.5.498 · Cited by 256
Brierley, J. D., Panzarella, T., Tsang, R. W., Gospodarowicz, M. K., & O'Sullivan, B. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2414::aid-cncr18>3.0.co;2-u · Cited by 254
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
Zafon, C., Obiols, G., Castellví, J., Tallada, N., Baena, J. A., Simó, R., & Mesa, J. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02555.x · Cited by 31
Metadata
- Authors
- DEGROOT, L. J., KAPLAN, E. L., MCCORMICK, M., & STRAUS, F. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1990-08
- Volume
- 71
- Issue
- 2
- Pages
- 414-424
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2057836926
- Cited by
- 1,049
- References
- 12
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.